Twist Bioscience stock edges higher with price consolidating above key support levels

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience up 0.24% today

Highlights

Twist Bioscience maintains a strong bullish trend, trading well above key support levels and displaying resilience across timeframes.
Momentum indicators remain largely bullish, but some signals point to overbought conditions and potential for brief consolidation.
Expected price action for the coming week is consolidation within the $88.00–$99.00 range, with a breakout above $94.10 likely triggering further upside.

Twist Bioscience also provides a link to additional RNA-relevant resources in the same message. Details are being clarified.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Uptrend sustained as short-term support holds above rising averages

Twist Bioscience (TWST) is currently trading at $91.55, placing it slightly above the MA-20 ($91.44), well above the MA-50 ($83.51) and MA-200 ($52.58). This MA configuration signals strength across short-, medium-, and long-term trends, while the Ichimoku Kijun sits at $94.10, acting as immediate resistance. Near-term support lies at the MA-20 ($91.44), with key support at the MA-50 ($83.51). Resistance is defined first by the Ichimoku Kijun ($94.10) and then by the MA-100 ($67.90), though the next actionable resistance level is close by rather than significantly higher.

Momentum mixed as overbought signals contrast with persistent weekly gains

Momentum indicators on D1 remain positive, with the MACD showing a strong buy and the ADX at 26.01 signaling a healthy trend. RSI is in a neutral-to-bullish zone at 53.19, and Stoch RSI is neutral, while CCI also sits near neutral, reflecting neither overbought nor oversold conditions. However, BBP points to overbought territory with pronounced buyer dominance, introducing some caution, especially as the AO signals short-term weakness in contrast to the broader positive picture. TWST has risen $1.28 (1.42%) over the past week, trading at $91.55 compared to a previous weekly close of $90.27. The current price is in the upper part of the weekly range, with weekly volatility at 15.11%. The stock’s weekly tone shows a sustained advance with some intraday consolidation.

Strong bullish bias as consolidation persists within broad upward channel

Looking ahead, the expected price range for TWST over the coming week is $88.00 to $99.00, which aligns with recent volatility and retains the bullish undertone seen in the indicators. With all major W1 signals (RSI, ADX, MACD, MA-50) on “Buy,” there is a very high probability (more than 80%) of a price increase, making further decline less likely. The baseline scenario anticipates continued consolidation between $88.00 and $99.00. A bullish move would see price breaking above $94.10 and possibly challenging the upper end of the range, while a bearish breakdown could drive retests toward $88.00 support. This outlook places TWST well above its 52-week low of $23.30 and within striking distance of the 52-week high of $105.41, confirming the strong year-to-date momentum.

Earlier, analysts noted that Twist Bioscience exhibited strong medium- and long-term bullish momentum, supported by sustained buyer interest but tempered by near-term overbought signals. The current analysis expands on this view by identifying a potential shift in market dynamics, with investors advised to closely monitor emerging resistance levels that could define the next phase of price action.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.